These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 25475039
21. Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer. Crawford BS, McNulty RM, Kraut EH, Turowski RC. Cancer Invest; 2009 Dec; 27(10):984-8. PubMed ID: 19909013 [Abstract] [Full Text] [Related]
22. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Ortega C, Montemurro F, Faggiuolo R, Vormola R, Nanni D, Goia F, Gilardino MO, Aglietta M. Acta Oncol; 2007 Dec; 46(5):664-8. PubMed ID: 17562443 [Abstract] [Full Text] [Related]
23. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid. García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E. Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097 [Abstract] [Full Text] [Related]
28. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases. Lee JJ, Cheng SJ, Wang YP, Jeng JH, Chiang CP, Kok SH. Head Neck; 2013 Jan 01; 35(1):E6-10. PubMed ID: 21523843 [Abstract] [Full Text] [Related]
30. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate. Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y. Basic Clin Pharmacol Toxicol; 2009 May 01; 104(5):384-92. PubMed ID: 19413658 [Abstract] [Full Text] [Related]
36. Bisphosphonates in prostate cancer: where are we and where should we go? Saad F. J Natl Cancer Inst; 2003 Sep 03; 95(17):1262-3. PubMed ID: 12953073 [No Abstract] [Full Text] [Related]
38. Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-analysis. Palmieri C, Fullarton JR, Brown J. Clin Cancer Res; 2013 Dec 15; 19(24):6863-72. PubMed ID: 24166910 [Abstract] [Full Text] [Related]